Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Reed, G. W.
  • Cannon, C. P.
  • Waalen, Jill
  • Teirstein, P. S.
  • Tanguay, J. F.
  • Berger, P. B.
  • Angiolillo, D. J.
  • Price, M. J.

publication date

  • February 2017

journal

  • Catheterization and Cardiovascular Interventions  Journal

subject areas

  • Aged
  • Blood Platelets
  • Chi-Square Distribution
  • Coronary Artery Disease
  • Dose-Response Relationship, Drug
  • Drug-Eluting Stents
  • Female
  • Humans
  • Linear Models
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Percutaneous Coronary Intervention
  • Platelet Activation
  • Platelet Aggregation Inhibitors
  • Platelet Function Tests
  • Prospective Studies
  • Purinergic P2Y Receptor Antagonists
  • Receptors, Purinergic P2Y12
  • Risk Factors
  • Smoking
  • Ticlopidine
  • Time Factors
  • Treatment Outcome
scroll to property group menus

Research

keywords

  • clopidogrel resistance
  • platelet function
  • platelet reactivity
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1522-1946

Digital Object Identifier (DOI)

  • 10.1002/ccd.26428

PubMed ID

  • 26909669
scroll to property group menus

Additional Document Info

start page

  • 190

end page

  • 198

volume

  • 89

issue

  • 2

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support